Krensavage Partners Having Strong 2018 Led By Contrarian Long

Rupert Hargreaves

Published onNovember 25, 2018

Updated on November 25, 2018

According to its third-quarter letter to investors, a copy of which has been reviewed by ValueWalk, Krensavage Partners is having an exceptionally strong 2018.

The health-care focused hedge fund managed by Michael Krensavage, was up 18.9% for the year to the end of September, compared to 10.6% for the S&P 500 and 16.6% for the S&P Healthcare Index.

Q3 hedge fund letters, conference, scoops etc

If you’re looking for more timely hedge fund insight, ValueWalk’s exclusive newsletter Hidden Value Stocks offers exclusive access to under-the-radar value hedge funds and their ideas. Click here to find out more and signup for a free no-obligation trial today.

Sector-leading

Over the past ten years, Krensavage has carved out a...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here

Rupert Hargreaves

Sign up now and get our in-depth FREE e-books on famous investors like Klarman, Dalio, Schloss, Munger Rupert is a committed value investor and regularly writes and invests following the principles set out by Benjamin Graham. He is the editor and co-owner of Hidden Value Stocks, a quarterly investment newsletter aimed at institutional investors. Rupert owns shares in Berkshire Hathaway. Rupert holds qualifications from the Chartered Institute For Securities & Investment and the CFA Society of the UK. Rupert covers everything value investing for Hedge Fund Alpha

Krensavage Partners Having Strong 2018 Led By Contrarian Long

Sector-leading

Login required to continue reading.

Get Your Business News